Table 2.
The effect of different treatments applied in the vineyard on individual phenolic compounds of Feteasca Neagra wines obtained in two vintages representative for the period 2010–2019
| Compound (mg L−1) | Vintage 2013 | Vintage 2014 | ANOVA | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Org C | Org CT | Conv C | Conv CT | Org C | Org CT | Conv C | Conv CT | Year (Y) | Treatment (T) | Yx T | |
| Gallic acid | 10.02 ± 2.30a | 10.94 ± 2.50a | 7.87 ± 1.70a | 7.92 ± 1.20a | 21.97 ± 2.80c | 23.42 ± 2.40c | 29.72 ± 3.20b | 35.15 ± 2.60a | **** | ns | **** |
| Syringic acid | 1.19 ± 0.23a | 1.15 ± 0.25a | 1.05 ± 0.27a | 1.05 ± 0.22a | 3.38 ± 0.8a | 3.19 ± 0.60a | 3.62 ± 0.90a | 2.97 ± 0.201a | **** | ns | **** |
| p-coumaric acid | 2.90 ± 0.70a | 3.09 ± 0.90a | 3.56 ± 0.74a | 3.66 ± 0.60a | 1.79 ± 0.30b | 2.43 ± 0.51b | 3.40 ± 0.30a | 3.96 ± 0.60a | ns | ** | ** |
| Catechin | 7.43 ± 1.20a | 8.23 ± 1.30a | 9.63 ± 1.50a | 10.17 ± 1.70a | 17.63 ± 2.10b | 19.47 ± 2.80b | 16.54 ± 3.20b | 24.47 ± 2.30a | **** | ns | **** |
| Epicatechin | 8.73 ± 1.60b | 14.43 ± 2.1a | 5.27 ± 1.80c | 12.63 ± 2.20a | 6.59 ± 1.20c | 17.10 ± 2.70a | 7.52 ± 1.80c | 12.50 ± 2.40b | ns | **** | **** |
| Rutin | 1.68 ± 0.06b | 2.06 ± 0.08a | 0.12 ± 0.05b | 0.24 ± 0.09b | 0.33 ± 0.03d | 0.77 ± 0.05a | 0.49 ± 0.02c | 0.68 ± 0.05b | ns | ** | **** |
| Quercetin | 0.13 ± 0.05ab | 0.23 ± 0.19a | 0.05 ± 0.02b | 0.06 ± 0.04b | 0.28 ± 0.06a | 0.32 ± 0.05a | 0.16 ± 0.07b | 0.38 ± 0.03a | *** | * | **** |
| t-resveratrol | 0.88 ± 0.03b | 1.06 ± 0.09a | 0.75 ± 0.05b | 1.08 ± 0.10a | 1.74 ± 0.09b | 2.14 ± 0.10a | 1.31 ± 0.07c | 1.40 ± 0.06c | **** | ns | **** |
| De | 0.67 ± 0.22b | 1.71 ± 0.63a | 0.50 ± 0.32b | 0.69 ± 0.37b | 1.75 ± 0.27b | 2.48 ± 0.33a | 1.00 ± 0.18c | 1.80 ± 0.36b | ** | ** | **** |
| Cy | 0.25 ± 0.11b | 0.59 ± 0.26a | 0.38 ± 0.10ab | 0.40 ± 0.13ab | 0.27 ± 0.10a | 0.29 ± 0.04a | 0.31 ± 0.09a | 0.37 ± 0.11a | ns | ns | ns |
| Pt | 0.92 ± 0.55a | 1.71 ± 0.38a | 1.00 ± 0.30a | 1.16 ± 0.52a | 4.26 ± 1.172ab | 5.93 ± 1.20a | 2.16 ± 1.06b | 3.90 ± 1.18ab | **** | ns | **** |
| Pe | 0.26 ± 0.11a | 0.39 ± 0.22a | 0.39 ± 0.22a | 0.43 ± 0.15a | 3.38 ± 0.52b | 4.64 ± 0.66a | 2.36 ± 0.30b | 5.19 ± 0.76a | **** | ns | **** |
| Mv | 18.91 ± 4.30a | 20.73 ± 2.60a | 16.08 ± 2.90a | 18.94 ± 3.20a | 32.75 ± 6.30ab | 43.29 ± 7.50a | 20.57 ± 6.20a | 31.56 ± 5.80ab | **** | ** | **** |
| Pea | 0.35 ± 0.10b | 0.35 ± 0.18b | 0.82 ± 0.26a | 0.74 ± 0.29ab | 0.51 ± 0.21a | 0.60 ± 0.16a | 0.51 ± 0.20a | 0.48 ± 0.18a | ns | ns | ns |
| Mva | 5.65 ± 1.62a | 6.96 ± 1.35a | 0.77 ± 0.28b | 0.84 ± 0.33b | 1.34 ± 0.30ab | 1.78 ± 0.35a | 1.04 ± 0.27b | 1.25 ± 0.38ab | * | ns | **** |
| Pec | 0.34 ± 0.20a | 0.37 ± 0.199a | 0.30 ± 0.18a | 0.33 ± 0.10a | 0.86 ± 0.21ab | 1.16 ± 0.32a | 0.54 ± 0.16b | 0.83 ± 0.20ab | **** | ns | **** |
| Mvc | 2.40 ± 0.30a | 1.47 ± 0.10b | 1.15 ± 0.10b | 1.31 ± 0.16b | 1.88 ± 0.33b | 2.53 ± 0.38a | 1.14 ± 0.27c | 1.66 ± 0.29bc | ns | *** | **** |
Org–organic system, Conv–conventional system, CT–30% cluster thinning, C–control; Means (n = 3) ± standard deviation followed by different lowercase letters in the line differ significantly according to the Duncan’s multiple range test for year (Y), treatment (T) and both, year and treatment (Y × T): ns: p > 0.05 (not significant), *p ≤ 0.05 (significant), **p ≤ 0.01 (highly significant), ***p ≤ 0.001 (very highly significant) and ****p ≤ 0.0001 (extremely significant)